Monday, August 31, 2026

Uncertainty Ahead? Berkshire Hathaway Sold Fewer Shares And Reduced Share Buybacks

Berkshire Hathaway's Q2 13F filing revealed a $293 billion portfolio of 44 companies. Analysis shows reduced share sales and buybacks amid market uncertainty.

LM Salvado
LM Salvado

August 18, 2021

Uncertainty Ahead? Berkshire Hathaway Sold Fewer Shares And Reduced Share Buybacks
(VIANEWS) - Berkshire Hathaway's second-quarter 13F was just released, providing us with an opportunity to examine the firm's publicly listed equities portfolio. Berkshire has a huge stable of wholly-owned businesses, thus this is only a small portion of their holdings. Berkshire Hathaway's $293 billion investment portfolio is made up of 44 firms and is highly concentrated, with the top five holdings accounting for more than 76% of the overall portfolio. Apple, Coca-Cola, American Express, Bank of America, and Kraft Heinz are the top five holdings. Although the 13F does not contain overseas equities, Berkshire announced the acquisition of about 5% of five Japanese trading businesses by the end of August 2020: Sumitomo Corp, Mitsubishi Corp, Marubeni Corp, Mitsui & Co. Ltd., and Itochu Corp. Buffett stated that they were long-term investments, and Berkshire may grow its share to up to 9.9 percent. Warren Buffett’s Berkshire Hathaway Inc. trimmed a lot of stakes and was an overall net seller of stocks  during the second quarter.

Investment out

Berkshire pulled back on Axalta Coating Systems Ltd, an American business that specializes in coatings for a wide range of industrial applications, materials, and industries. The company also pulled back by 2.3% of Chevron Corp. holding, an American multinational energy corporation. Berkshire has held General Motors shares for almost ten years, then pulled back on the investment in recent quarters. Buffett’s company cut its stake in the automaker by about 10% during the second quarter even as the stock gained nearly 3% during the period. The firm also trimmed its bets on pharmaceutical and biotechnology companies including AbbVie Inc., Biogen, and Bristol-Myers Squibb. There seems to be a trend of decreasing exposure to pharmaceutical equities, many of which were bought in the third quarter of 2020. Berkshire trimmed its Marsh McLennan holding nearly 21% during the second quarter. Marsh McLennan is a New York-based Company offering global professional services specializing in insurance brokerage, risk management, and reinsurance services.

Investment in

Buffett’s firm boosted isn't just trimming stakes. Insurance company, Aon Plc's stake rose 7.3%, even after the company recently canceled its planned $30 billion takeover of rival Willis Towers Watson Plc. Another example is Kroger Co, an American retailer which is the largest supermarket in the United States by revenue and the second-largest general retailer. Berkshire’s Kroger stake was up 21% during the second quarter.

Last quarter, Berkshire Hathaway sold fewer shares and reduced share buybacks

According to PWC, Buffett’s firm sold a net $1.1 billion in stocks, down from $3.9 billion in the first quarter but Berkshire spent $6 billion on share repurchases, a decrease from $6.6 billion in the previous quarter. Berkshire's 13F analysis suggests that finding bargains in the second quarter was challenging.

In this story · Knowledge Files

LM Salvado
LM Salvado

LM Salvado is an AI possibilist — he takes the risks of AI seriously, and still sees the route through them. Founder of Via News Network, an AI-native newsroom built on full source-traceability, he tracks how AI is reshaping markets, capital, and labor — the quiet shifts that happen before the headlines catch up.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Hawkish Fed Signals at Jackson Hole Pressure Rate-Sensitive Assets
Kevin Warsh's hawkish inflation remarks at Jackson Hole, alongside a steady drumbeat of Federal Reserve testimony from Powell, Barr, Bowman and other officials on supervision, regulation and monetary policy, signal continued vigilance against inflation rather than an imminent easing cycle. Rate-sensitive and precious-metals-linked names such as SSR Mining sold off the same day, consistent with markets repricing for a firmer-for-longer policy stance.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,979
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,979 facts checked against source5,261 source documents archived
Query this data → isubstrate.com